Skip to main content

Table 1 General characteristics of 1318 respondents

From: Obesity management in polycystic ovary syndrome: disparity in knowledge between obstetrician-gynecologists and reproductive endocrinologists in China

 

Overall (n = 1318)

Repro-Endo (n = 187)

OB-Gyn (n = 1131)

P-value

Sex

 female

1282 (97.3)

177 (94.7)

1105 (97.7)

.018

 male

36 (2.7)

10 (5.3)

26 (2.3)

.018

Age

 18–35

226 (17.1)

22 (11.7)

204 (18.0)

.035

 36–45

514 (39.0)

76 (40.7)

438 (38.7)

NS

 ≥ 46

578 (43.9)

89 (47.6)

489 (43.3)

NS

Hospital grade

 3

793 (60.2)

123 (65.8)

670 (59.2)

NS

 2

456 (34.6)

61 (32.6)

395 (34.9)

NS

 1

69 (5.2)

3 (1.6)

66 (5.9)

.016

No. of patients with PCOS treated annually

 < 50

849 (64.4)

54 (28.8)

795 (70.3)

<.001

 51–200

358 (27.2)

86 (46.0)

272 (24.0)

<.001

 > 200

111 (8.4)

47 (25.2)

64 (5.7)

<.001

Main reason for clinic attendance in patients with PCOS

 Menstrual disorders

1062 (80.6)

130 (69.5)

932 (82.4)

<.001

 Infertility

226 (17.1)

54 (29.0)

172 (15.2)

<.001

 Hirsutism/acne

9 (0.7)

1 (0.5)

8 (0.7)

NS

 Obesity/IR

21 (1.6)

2 (1.0)

19 (1.7)

NS

Estimated national prevalence of overweight/obesity in patients with PCOS

 0–30%

384 (29.1)

28 (15.0)

356 (31.5)

<.001

 31–50%

541 (41.1)

87 (46.5)

454 (40.1)

NS

 51–80%

331 (25.1)

64 (34.2)

267 (23.6)

.002

 > 80%

62 (4.7)

8 (4.3)

54 (4.8)

NS

  1. Abbreviations: Repro-Endo Reproductive endocrinologist, OB-Gyn Obstetrician-gynecologists, PCOS Polycystic ovary syndrome